Akèy › Skleroz an milti relaps-remitan › Illinois › Chicago
Etid klinik pou Skleroz an milti relaps-remitan nan Chicago, IL
5 etid pou Skleroz an milti relaps-remitan ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Ap rekriteFaz 3
- University of Chicago Medical Center, Chicago
Intermittent Hypoxia in Persons With Multiple Sclerosis
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Ap rekriteFaz 4
- Northwestern Memorial Hospital, Chicago
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
Home Based Functional Balance Intervention for Multiple Sclerosis
Ap rekrite
- University of Illinois at Chicago, Chicago
Etid Skleroz an milti relaps-remitan nan lòt vil
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.